Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)
暂无分享,去创建一个
P. Hari | M. Pasquini | S. Janz | A. D’Souza | S. Chhabra | B. Dhakal | S. Radhakrishnan | Jing Dong | Lindsay Hammons | Shabi Haider | A. Zamora | Meera Mohan